Kalaris Therapeutics, Inc. · NASDAQ:KLRS
Srinivas Akkaraju bought 244,300 Kalaris Therapeutics, Inc. shares (Form 4)
Traded May 20, 2026 · Filed May 22, 2026
On May 20, 2026, Srinivas Akkaraju (10% owner) bought 244,300 Kalaris Therapeutics, Inc. shares at US$4.83 for US$1.18M, leaving 19,408 shares. Filed May 22, 2026 (Form 4).
- Bought
- 244,300 shares
- Price
- US$4.83
- Value
- US$1.18M
- Holding after
- 19,408 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 20, 2026 | Common Stock | Buy | 244,300 | US$4.83 | 2,224,147 | Indirect |
| May 20, 2026 | Common Stock | Other | 66,906 | 10,657,028 | Indirect | |
| May 20, 2026 | Common Stock | Other | 14,937 | 14,937 | Indirect | |
| May 20, 2026 | Common Stock | Other | 4,471 | 19,408 | Indirect |
Source
Related
- Kalaris Therapeutics, Inc.
- Srinivas Akkaraju
- Kalaris Therapeutics, Inc. shareholders
- Schedule 13D/A · Akkaraju Srinivas · May 22, 2026
- Schedule 13G · Rtw Investments, LP · Feb 17, 2026
- Schedule 13D/A · Akkaraju Srinivas · Feb 17, 2026
- Schedule 13D/A · Akkaraju Srinivas · Dec 22, 2025
- Schedule 13G/A · Invus Public Equities, L.P. · Jul 29, 2025